Literature DB >> 12089126

Bone mineral density in patients with classic galactosaemia.

M E Rubio-Gozalbo1, S Hamming, M J P G van Kroonenburgh, J A Bakker, C Vermeer, P Ph Forget.   

Abstract

BACKGROUND: Diminished bone mineral density (BMD) is a well known complication in women with classic galactosaemia caused by premature ovarian failure. Diminished BMD in prepubertal patients of either sex has, however, only been reported once. AIM: To assess BMD in children with classic galactosaemia.
METHODS: Eleven treated patients (five males, six females, aged 2-18 years) had BMD determined by dual energy x ray absorptiometry. Two measurements were performed, an areal measurement of the total body and a volumetric measurement of the femoral neck. Results were expressed as Z scores. Dietary calcium intake, blood calcium, phosphate, vitamin D, parathormone, and markers of bone formation (bone alkaline phosphatase, osteocalcin) and bone resorption (NTX) were determined.
RESULTS: All patients had a significantly diminished BMD. Mean Z score of the volumetric BMD was -1.76 (range -0.7 to -3.3), and of the areal BMD -0.99 (range -0.5 to -1.4). Dietary calcium intake and calcium, phosphate, parathormone, bone alkaline phosphatase, vitamin D metabolites, and osteocalcin (free and carboxylated) were normal in all patients. NTX levels in blood were significantly lower (p < 0.001) than in control subjects.
CONCLUSION: BMD in this group of children of both sexes with classic galactosaemia under dietary treatment was decreased. Lower NTX levels in galactosaemics point to an apparent decreased bone resorption.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089126      PMCID: PMC1751149          DOI: 10.1136/adc.87.1.57

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Volumetric bone mineral density in normal subjects, aged 5-27 years.

Authors:  P W Lu; C T Cowell; S A LLoyd-Jones; J N Briody; R Howman-Giles
Journal:  J Clin Endocrinol Metab       Date:  1996-04       Impact factor: 5.958

Review 2.  Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase.

Authors:  C Vermeer
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

3.  Effect of hypogonadism and deficient calcium intake on bone density in patients with galactosemia.

Authors:  F R Kaufman; M L Loro; C Azen; E Wenz; V Gilsanz
Journal:  J Pediatr       Date:  1993-09       Impact factor: 4.406

Review 4.  Role of vitamin K in bone metabolism.

Authors:  C Vermeer; K S Jie; M H Knapen
Journal:  Annu Rev Nutr       Date:  1995       Impact factor: 11.848

Review 5.  Vitamin K nutrition and osteoporosis.

Authors:  N C Binkley; J W Suttie
Journal:  J Nutr       Date:  1995-07       Impact factor: 4.798

6.  Volumetric bone mineral density--a potential role in paediatrics.

Authors:  C T Cowell; P W Lu; S A Lloyd-Jones; J N Briody; J R Allen; I R Humphries; E Reed; J Knight; R Howman-Giles; K Gaskin
Journal:  Acta Paediatr Suppl       Date:  1995-09
  6 in total
  15 in total

1.  Introduction to the Maastricht workshop: lessons from the past and new directions in galactosemia.

Authors:  Gerard T Berry; Louis J Elsas
Journal:  J Inherit Metab Dis       Date:  2010-11-30       Impact factor: 4.982

2.  Body composition in children with galactosaemia.

Authors:  B Panis; P Ph Forget; F H Nieman; M J P G van Kroonenburgh; M E Rubio-Gozalbo
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Living situation, occupation and health-related quality of life in adult patients with classic galactosemia.

Authors:  Björn Hoffmann; Nico Dragano; Susanne Schweitzer-Krantz
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

Review 4.  Classical galactosaemia revisited.

Authors:  Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

5.  Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia.

Authors:  Bijina Balakrishnan; Ding An; Vi Nguyen; Christine DeAntonis; Paolo G V Martini; Kent Lai
Journal:  Mol Ther       Date:  2019-09-19       Impact factor: 11.454

6.  Diversity of approaches to classic galactosemia around the world: a comparison of diagnosis, intervention, and outcomes.

Authors:  Patricia P Jumbo-Lucioni; Kathryn Garber; John Kiel; Ivo Baric; Gerard T Berry; Annet Bosch; Alberto Burlina; Ana Chiesa; Maria Luz Couce Pico; Sylvia C Estrada; Howard Henderson; Nancy Leslie; Nicola Longo; Andrew A M Morris; Carlett Ramirez-Farias; Susanne Schweitzer-Krantz; Susanne Scheweitzer-Krantz; Catherine Lynn T Silao; Marcela Vela-Amieva; Susan Waisbren; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2012-03-27       Impact factor: 4.982

Review 7.  Primary ovarian insufficiency in classic galactosemia: current understanding and future research opportunities.

Authors:  Mili Thakur; Gerald Feldman; Elizabeth E Puscheck
Journal:  J Assist Reprod Genet       Date:  2017-09-20       Impact factor: 3.412

8.  Bone Health in Classic Galactosemia: Systematic Review and Meta-Analysis.

Authors:  Britt van Erven; Lindsey Welling; Sandra C van Calcar; Artemis Doulgeraki; François Eyskens; Joanna Gribben; Eileen P Treacy; Rein Vos; Susan E Waisbren; M Estela Rubio-Gozalbo; Annet M Bosch
Journal:  JIMD Rep       Date:  2016-12-20

9.  Revised proposal for the prevention of low bone mass in patients with classic galactosemia.

Authors:  Britt van Erven; Myrna M M Römers; M Estela Rubio-Gozalbo
Journal:  JIMD Rep       Date:  2014-08-03

10.  Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

Authors:  Ashwini Maratha; Hugh-Owen Colhoun; Ina Knerr; Karen P Coss; Peter Doran; Eileen P Treacy
Journal:  JIMD Rep       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.